CIK 0000874015
- Large accelerated filer
IONIS PHARMACEUTICALS INC
Sign in to watch- Ticker
- IONS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- Operating
- EIN
- 330336973
- Phone
- +1 760-931-9200
- Business address
- 2855 GAZELLE COURT, CARLSBAD, CA, 92010
- Former names
- ISIS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $148,200
- in 1 filing
- Open-market sales, last 90 days
- $61,389
- in 2 filings
Net +$86,811. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-12-21 | BENNETT C FRANK EVP, Chief Scientific Officer | Sale 10b5-1 | −16,113 | $49.29 | $794K | 65,754 |
| 2023-12-21 | BENNETT C FRANK EVP, Chief Scientific Officer | Exercise or conversion · Non-Qualified Stock Option (right to buy) 10b5-1 | −16,113 | 0 | ||
| 2023-12-20 | BENNETT C FRANK EVP, Chief Scientific Officer | Exercise or conversion 10b5-1 | +6,500 | $47.34 | $308K | 72,254 |
| 2023-12-20 | BENNETT C FRANK EVP, Chief Scientific Officer | Sale 10b5-1 | −6,500 | $49.64 | $323K | 65,754 |
| 2023-12-20 | BENNETT C FRANK EVP, Chief Scientific Officer | Exercise or conversion · Non-Qualified Stock Option (right to buy) 10b5-1 | −6,500 | 16,113 | ||
| 2023-12-14 | BENNETT C FRANK EVP, Chief Scientific Officer | Exercise or conversion 10b5-1 | +14,002 | $47.34 | $663K | 79,756 |
| 2023-12-14 | BENNETT C FRANK EVP, Chief Scientific Officer | Sale 10b5-1 | −14,002 | $49.21 | $689K | 65,754 |
| 2023-12-14 | BENNETT C FRANK EVP, Chief Scientific Officer | Exercise or conversion 10b5-1 | +8,610 | $47.34 | $408K | 74,364 |
| 2023-12-14 | BENNETT C FRANK EVP, Chief Scientific Officer | Sale 10b5-1 | −8,610 | $50.19 | $432K | 65,754 |
| 2023-12-14 | BENNETT C FRANK EVP, Chief Scientific Officer | Exercise or conversion · Non-Qualified Stock Option (right to buy) 10b5-1 | −14,002 | 31,223 | ||
| 2023-12-14 | BENNETT C FRANK EVP, Chief Scientific Officer | Exercise or conversion · Non-Qualified Stock Option (right to buy) 10b5-1 | −8,610 | 22,613 | ||
| 2023-09-28 | BENNETT C FRANK EVP, Chief Scientific Officer | Sale 10b5-1 | −4,460 | $46.50 | $207K | 65,754 |
| 2023-08-31 | BENNETT C FRANK Officer Level 14 | Other acquisition | +180 | $30.56 | $6K | 70,214 |
| 2023-02-28 | BENNETT C FRANK EVP, Chief Scientific Officer | Other acquisition | +383 | $30.52 | $12K | 70,034 |
| 2023-02-06 | BENNETT C FRANK EVP, Chief Scientific Officer | Sale | −1,813 | $40.57 | $74K | 69,651 |
| 2023-02-03 | BENNETT C FRANK EVP, Chief Scientific Officer | Grant or award | +3,609 | 71,464 | ||
| 2023-01-18 | BENNETT C FRANK EVP, Chief Scientific Officer | Sale | −6,978 | $38.89 | $271K | 67,855 |
| 2023-01-17 | BENNETT C FRANK EVP, Chief Scientific Officer | Exercise or conversion | +19,417 | 74,833 | ||
| 2023-01-17 | BENNETT C FRANK EVP, Chief Scientific Officer | Exercise or conversion · Restricted Stock Unit | −19,417 | 21,414 | ||
| 2023-01-15 | BENNETT C FRANK EVP, Chief Scientific Officer | Grant or award · Performance Restricted Stock Units | +13,656 | 24,482 |
Page 4 of 5 · 82 trades